BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 23707626)

  • 1. Validation of Memorial Sloan-Kettering Cancer Center nomogram for prediction of non-sentinel lymph node metastasis in sentinel lymph node positive breast cancer patients an international comparison.
    Kuo YL; Chen WC; Yao WJ; Cheng L; Hsu HP; Lai HW; Kuo SJ; Chen DR; Chang TW
    Int J Surg; 2013; 11(7):538-43. PubMed ID: 23707626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive probability of four different breast cancer nomograms for nonsentinel axillary lymph node metastasis in positive sentinel node biopsy.
    Gur AS; Unal B; Johnson R; Ahrendt G; Bonaventura M; Gordon P; Soran A
    J Am Coll Surg; 2009 Feb; 208(2):229-35. PubMed ID: 19228534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
    Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
    Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a nomogram to predict the risk of nonsentinel lymph node metastases in breast cancer patients with a positive sentinel node biopsy: validation of the MSKCC breast nomogram.
    van la Parra RF; Ernst MF; Bevilacqua JL; Mol SJ; Van Zee KJ; Broekman JM; Bosscha K
    Ann Surg Oncol; 2009 May; 16(5):1128-35. PubMed ID: 19252954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for sentinel lymph node metastasis and validation study of the MSKCC nomogram in breast cancer patients.
    Qiu PF; Liu JJ; Wang YS; Yang GR; Liu YB; Sun X; Wang CJ; Zhang ZP
    Jpn J Clin Oncol; 2012 Nov; 42(11):1002-7. PubMed ID: 23100610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the likelihood of additional lymph node metastasis in sentinel lymph node positive breast cancer: validation of the Memorial Sloan-Kettering Cancer Centre (MSKCC) nomogram.
    Chue KM; Yong WS; Thike AA; Ahmed SS; Li HH; Wong CY; Ho GH; Madhukumar P; Tan BK; Ong KW; Tan PH
    J Clin Pathol; 2014 Feb; 67(2):112-9. PubMed ID: 24048026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node micrometastasis and risk of non-sentinel lymph node metastasis: validation of two breast cancer nomograms.
    D'Eredità G; Troilo VL; Giardina C; Napoli A; Rubini G; Fischetti F; Berardi T
    Clin Breast Cancer; 2010 Dec; 10(6):445-51. PubMed ID: 21147687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after positive sentinel node biopsy.
    Alran S; De Rycke Y; Fourchotte V; Charitansky H; Laki F; Falcou MC; Benamor M; Freneaux P; Salmon RJ; ; Sigal-Zafrani B
    Ann Surg Oncol; 2007 Aug; 14(8):2195-201. PubMed ID: 17294071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of breast cancer nomograms for predicting the non-sentinel lymph node metastases after a positive sentinel lymph node biopsy in a multi-center study.
    Gur AS; Unal B; Ozbek U; Ozmen V; Aydogan F; Gokgoz S; Gulluoglu BM; Aksaz E; Ozbas S; Baskan S; Koyuncu A; Soran A;
    Eur J Surg Oncol; 2010 Jan; 36(1):30-5. PubMed ID: 19535217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A model for predicting non-sentinel lymph node metastatic disease when the sentinel lymph node is positive.
    Pal A; Provenzano E; Duffy SW; Pinder SE; Purushotham AD
    Br J Surg; 2008 Mar; 95(3):302-9. PubMed ID: 17876750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of Memorial Sloan-Kettering Cancer Center nomogram in clinical decision making for sentinel lymph node-positive breast cancer.
    van den Hoven I; Kuijt GP; Voogd AC; van Beek MW; Roumen RM
    Br J Surg; 2010 Nov; 97(11):1653-8. PubMed ID: 20641050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the Memorial Sloan-Kettering Cancer Center nomogram to predict sentinel lymph node metastases in a Dutch breast cancer population.
    van la Parra RF; Francissen CM; Peer PG; Ernst MF; de Roos WK; Van Zee KJ; Bosscha K
    Eur J Cancer; 2013 Feb; 49(3):564-71. PubMed ID: 22975214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MSKCC nomogram for prediction the likelihood of non-sentinel node involvement in a German breast cancer population.
    Klar M; Jochmann A; Foeldi M; Stumpf M; Gitsch G; Stickeler E; Watermann D
    Breast Cancer Res Treat; 2008 Dec; 112(3):523-31. PubMed ID: 18172758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a breast cancer nomogram for predicting the likelihood of additional nodal metastases in patients with a positive sentinel node biopsy.
    Scomersi S; Torelli L; Zanconati F; Tonutti M; Dore F; Bortul M
    Ann Ital Chir; 2012; 83(6):461-8. PubMed ID: 23110902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
    Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
    Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good prediction of the likelihood for sentinel lymph node metastasis by using the MSKCC nomogram in a German breast cancer population.
    Klar M; Foeldi M; Markert S; Gitsch G; Stickeler E; Watermann D
    Ann Surg Oncol; 2009 May; 16(5):1136-42. PubMed ID: 19259742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High intersystem variability for the prediction of additional axillary non-sentinel lymph node involvement in individual patients with sentinel node-positive breast cancer.
    van den Hoven I; Kuijt GP; Voogd AC; Roumen RM
    Ann Surg Oncol; 2012 Jun; 19(6):1841-9. PubMed ID: 22207045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting likelihood of having four or more positive nodes in patient with sentinel lymph node-positive breast cancer: a nomogram validation study.
    Unal B; Gur AS; Beriwal S; Tang G; Johnson R; Ahrendt G; Bonaventura M; Soran A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1035-40. PubMed ID: 19327916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the performance of the Stanford Online Calculator for the prediction of nonsentinel lymph node metastasis in sentinel lymph node-positive breast cancer patients.
    Scow JS; Degnim AC; Hoskin TL; Reynolds C; Boughey JC
    Cancer; 2009 Sep; 115(18):4064-70. PubMed ID: 19517477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can nomograms predict non-sentinel lymph node metastasis after neoadjuvant chemotherapy in sentinel lymph node-positive breast cancer patients?
    Unal B; Gur AS; Ahrendt G; Johnson R; Bonaventura M; Soran A
    Clin Breast Cancer; 2009 May; 9(2):92-5. PubMed ID: 19433389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.